About: PB-22

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

PB-22 (QUPIC, SGT-21 or 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent, and detected being sold in synthetic cannabis products in Japan in 2013. PB-22 represents a structurally unique synthetic cannabinoid chemotype, since it contains an ester linker at the indole 3-position, rather than the precedented ketone of JWH-018 and its analogs, or the amide of APICA and its analogs.

Property Value
dbo:abstract
  • PB-22 (QUPIC, SGT-21 or 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent, and detected being sold in synthetic cannabis products in Japan in 2013. PB-22 represents a structurally unique synthetic cannabinoid chemotype, since it contains an ester linker at the indole 3-position, rather than the precedented ketone of JWH-018 and its analogs, or the amide of APICA and its analogs. PB-22 has an EC50 of 5.1 nM for human CB1 receptors, and 37 nM for human CB2 receptors. PB-22 produces bradycardia and hypothermia in rats at doses of 0.3–3 mg/kg, suggesting potent cannabinoid-like activity. The magnitude and duration of hypothermia induced in rats by PB-22 was notably greater than JWH-018, AM-2201, UR-144, XLR-11, APICA, or STS-135, with a reduction of body temperature still observable six hours after dosing. One clinical toxicology study found PB-22 to be the cause of seizures in a human and his dog. (en)
dbo:casNumber
  • 1400742-17-7
dbo:fdaUniiCode
  • QM6J8F29FE
dbo:thumbnail
dbo:wikiPageID
  • 38911500 (xsd:integer)
dbo:wikiPageLength
  • 8014 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1082425789 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 23 (xsd:integer)
dbp:casNumber
  • 1400742 (xsd:integer)
dbp:chemspiderid
  • 29339966 (xsd:integer)
dbp:h
  • 22 (xsd:integer)
dbp:iupacName
  • 1 (xsd:integer)
dbp:legalCa
  • Schedule II (en)
dbp:legalDe
  • Anlage II (en)
dbp:legalUk
  • Class B (en)
dbp:legalUs
  • Schedule I (en)
dbp:n
  • 2 (xsd:integer)
dbp:o
  • 2 (xsd:integer)
dbp:smiles
  • CCCCCN1C=CCOC3=CC=CC4=C3N=CC=C4 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • ZAVGICCEAOUWFM-UHFFFAOYSA-N (en)
dbp:unii
  • QM6J8F29FE (en)
dbp:width
  • 200 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • PB-22 (QUPIC, SGT-21 or 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent, and detected being sold in synthetic cannabis products in Japan in 2013. PB-22 represents a structurally unique synthetic cannabinoid chemotype, since it contains an ester linker at the indole 3-position, rather than the precedented ketone of JWH-018 and its analogs, or the amide of APICA and its analogs. (en)
rdfs:label
  • PB-22 (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License